Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., which operated on Nasdaq under the ticker HSAQ as a healthcare and life sciences focused blank check company, filed a 10-K/A amended annual report with the Securities and Exchange Commission on March 31, 2022. The SPAC completed its initial public offering in 2021 and identified Orchestra BioMed as its target, a biomedical company developing bioelectronic and drug-device combination therapies for cardiovascular disease. The amended annual filing covered required disclosures during the vehicle's active search and combination period. Orchestra BioMed subsequently completed its business combination and continues to operate in the medical device and life sciences sector. Investors seeking the full sponsor profile, deal timeline, and filing history for HSAQ can sign up for complete data on SpacDesk.